Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Operating expenses
Selling, general and administrative	$ 2,302,747	$ 3,001,418	$ 4,068,770	$ 4,616,987
Research and development	846,853	1,293,467	1,929,089	1,748,559
Impairment of deposit on asset purchase agreement	3,500,000		3,500,000
Total operating expenses	6,649,600	4,294,885	9,497,859	6,365,546
Loss from operations	(6,649,600)	(4,294,885)	(9,497,859)	(6,365,546)
Other income (expense)
Interest expense	(213,996)		(213,996)
Change in fair value of contingent warrant liability	(1,674)	30,303	(59)	30,303
Total other income (expense)	(215,670)	30,303	(214,055)	30,303
Net loss	(6,865,270)	(4,264,582)	(9,711,914)	(6,335,243)
Cumulative preferred stock dividends				96,359
Net loss applicable to common stockholders	$ (6,865,270)	$ (4,264,582)	$ (9,711,914)	$ (6,431,602)
Net loss per share attributable to common stockholders, basic (in Dollars per share)	$ (0.43)	$ (0.36)	$ (0.61)	$ (0.7)
Weighted average number of common shares outstanding, basic (in Shares)	15,906,725	11,995,832	15,908,560	9,226,621